Genomic Valley Biotech Limited has initiated the closure of its trading window for insiders.

This closure is for the purpose of considering the financial results for the quarter.

During this period, employees, directors, key managerial personnel, designated persons, and their immediate relatives are restricted from trading in the company's shares.

The trading window will reopen 48 hours after the financial results are announced.

The company will soon announce the board meeting date for these results.